Production (Stage)
BioSig Technologies, Inc.
BSGM
$5.23
-$0.63-10.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -3.70% | 122.22% | -72.34% | -85.45% | -90.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.70% | 122.22% | -72.34% | -85.45% | -90.46% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -3.70% | 122.22% | -65.79% | -81.65% | -88.05% |
| SG&A Expenses | -40.63% | -49.61% | -35.73% | -40.37% | -7.11% |
| Depreciation & Amortization | -63.10% | -47.92% | -28.49% | -9.04% | 10.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.90% | -55.66% | -40.20% | -41.55% | -9.42% |
| Operating Income | 48.96% | 55.78% | 40.04% | 41.17% | 8.56% |
| Income Before Tax | 60.67% | 63.96% | 48.01% | 45.29% | 6.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 60.67% | 63.96% | 48.01% | 45.29% | 6.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 95.88% | 102.56% | 122.45% | -280.25% | -345.57% |
| Net Income | 61.21% | 64.43% | 48.98% | 43.53% | 4.96% |
| EBIT | 48.96% | 55.78% | 40.04% | 41.17% | 8.56% |
| EBITDA | 48.75% | 55.88% | 40.18% | 41.52% | 8.79% |
| EPS Basic | 80.76% | 79.17% | 68.82% | 64.63% | 40.55% |
| Normalized Basic EPS | 75.04% | 76.05% | 66.30% | 62.45% | 39.97% |
| EPS Diluted | 80.76% | 79.17% | 68.82% | 64.63% | 40.55% |
| Normalized Diluted EPS | 75.04% | 76.05% | 66.30% | 62.45% | 39.97% |
| Average Basic Shares Outstanding | 102.57% | 90.69% | 84.09% | 70.64% | 67.15% |
| Average Diluted Shares Outstanding | 102.57% | 90.69% | 84.09% | 70.64% | 67.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |